ORIGINAL RESEARCH article
Front. Immunol.
Sec. Systems Immunology
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1645382
Integration of Multi-Omics and Machine Learning Strategies Identifies Immune-Related Candidate Biomarkers in Inflammation-Associated Hypertrophic Cardiomyopathy
Provisionally accepted- 1People's Hospital of Baise, Baise, China
- 2Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease frequently leading to heart failure. Although sarcomeric gene mutations are known, they only account for a subset of cases. The role of immune dysregulation in HCM progression has gained increasing attention, necessitating the exploration of immune-related biomarkers and therapeutic targets. This study integrates Mendelian randomization (MR), transcriptomics, machine learning, and experimental validation to investigate the immune mechanisms underlying HCM. Methods: We analyzed three transcriptomic datasets from the GEO database (210 healthy controls, 152 HCM patients) and identified differentially expressed genes (DEGs) using the R package limma. MR analysis was performed on 19,942 expression quantitative trait loci (eQTLs) and HCM cases using the TwoSampleMR package. Machine learning (10 algorithms) was employed to construct diagnostic models, and SHAP analysis was applied to assess key gene contributions. Functional enrichment was performed with clusterProfiler, diagnostic performance was evaluated via ROC curves, and immune cell infiltration was analyzed using CIBERSORT. A competing endogenous RNA (ceRNA) network was constructed, and drug targets were predicted via the DGIdb database. Key gene expression was validated by qPCR. Results: We identified 472 DEGs and 205 HCM-associated loci, narrowing down to seven key genes: RNF165, SNCA, SRGN, MARCO, STEAP4, SIGLEC9, and TKT. These genes were enriched in immune-related pathways (e.g., cytokine activity, leukocyte migration, JAK-STAT signaling). The Random Forest model exhibited the highest diagnostic performance (AUC: 0.939), with SHAP analysis revealing MARCO as the top contributor. Gene expression was associated with immune cell infiltration: HCM samples showed increased CD4+ T cells and M0 macrophages but decreased M2 macrophages and neutrophils. The ceRNA network comprised 5 mRNAs, 40 miRNAs, and 152 lncRNAs. SRGN and SNCA were identified as potential targets for heparin and 33 other drugs, respectively. qRT-PCR performed on a small number of myocardial samples supported expression trends of the identified genes, in line with transcriptomic analysis. Conclusion: This study reveals immune-related mechanistic biomarkers and potential therapeutic targets in HCM, highlighting the role of immune dysregulation in disease progression. Machine learning and SHAP analysis improved diagnostic model interpretability, providing a basis for future development of non-invasive diagnostic tools.
Keywords: Hypertrophic Cardiomyopathy, Multi-approach, machine learning, biomarkers, Immune infiltration
Received: 11 Jun 2025; Accepted: 15 Sep 2025.
Copyright: © 2025 Liang, Wang, Nong, Tao and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Dalang Fang, fangdalang@stu.gxmu.edu.cn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.